• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

21 世纪的疫苗。

Vaccines for the 21st century.

机构信息

Novartis Vaccines, Siena, Italy.

Novartis Vaccines, Siena, Italy

出版信息

EMBO Mol Med. 2014 Jun;6(6):708-20. doi: 10.1002/emmm.201403876. Epub 2014 Apr 6.

DOI:10.1002/emmm.201403876
PMID:24803000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4203350/
Abstract

In the last century, vaccination has been the most effective medical intervention to reduce death and morbidity caused by infectious diseases. It is believed that vaccines save at least 2-3 million lives per year worldwide. Smallpox has been eradicated and polio has almost disappeared worldwide through global vaccine campaigns. Most of the viral and bacterial infections that traditionally affected children have been drastically reduced thanks to national immunization programs in developed countries. However, many diseases are not yet preventable by vaccination, and vaccines have not been fully exploited for target populations such as elderly and pregnant women. This review focuses on the state of the art of recent clinical trials of vaccines for major unmet medical needs such as HIV, malaria, TB, and cancer. In addition, we describe the innovative technologies currently used in vaccine research and development including adjuvants, vectors, nucleic acid vaccines, and structure-based antigen design. The hope is that thanks to these technologies, more diseases will be addressed in the 21st century by novel preventative and therapeutic vaccines.

摘要

在上个世纪,疫苗接种是减少传染病导致的死亡和发病的最有效医学干预手段。人们相信,疫苗每年在全球范围内至少挽救了 200 至 300 万人的生命。通过全球疫苗接种活动,天花已被根除,小儿麻痹症在全球范围内几乎消失。由于发达国家的国家免疫规划,大多数传统上影响儿童的病毒和细菌性感染已大大减少。然而,许多疾病仍然无法通过疫苗预防,并且疫苗在目标人群(如老年人和孕妇)中的应用尚未得到充分发挥。本综述重点介绍了针对重大未满足医疗需求的疫苗的最新临床试验现状,例如艾滋病毒、疟疾、结核病和癌症。此外,我们还描述了目前在疫苗研发中使用的创新技术,包括佐剂、载体、核酸疫苗和基于结构的抗原设计。希望在 21 世纪,由于这些技术的应用,更多的疾病将通过新型预防和治疗性疫苗得到解决。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd75/4203350/47cc17564ee6/emmm0006-0708-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd75/4203350/1c822a6ddcb7/emmm0006-0708-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd75/4203350/2fa9f99719f1/emmm0006-0708-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd75/4203350/47cc17564ee6/emmm0006-0708-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd75/4203350/1c822a6ddcb7/emmm0006-0708-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd75/4203350/2fa9f99719f1/emmm0006-0708-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd75/4203350/47cc17564ee6/emmm0006-0708-f3.jpg

相似文献

1
Vaccines for the 21st century.21 世纪的疫苗。
EMBO Mol Med. 2014 Jun;6(6):708-20. doi: 10.1002/emmm.201403876. Epub 2014 Apr 6.
2
A 2020 vision for vaccines against HIV, tuberculosis and malaria.针对艾滋病毒、结核病和疟疾疫苗的 2020 年愿景。
Nature. 2011 May 26;473(7348):463-9. doi: 10.1038/nature10124.
3
Vaccinology: past achievements, present roadblocks and future promises.疫苗学:过去的成就、当前的障碍及未来的前景
Vaccine. 2003 Jan 30;21(7-8):593-5. doi: 10.1016/s0264-410x(02)00702-8.
4
Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.非洲艾滋病毒/艾滋病、结核病和疟疾疫苗试验中的趋同伦理问题:世界卫生组织/艾滋病规划署非洲艾滋病疫苗方案的伦理、法律和人权合作中心协商会议报告,2009 年 2 月 10 日至 11 日,南非德班。
BMC Med Ethics. 2010 Mar 9;11:3. doi: 10.1186/1472-6939-11-3.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.针对贫困相关疾病的异源初免-加强疫苗接种:优势与未来前景
Expert Rev Vaccines. 2009 May;8(5):577-92. doi: 10.1586/erv.09.14.
7
Challenges for Vaccinologists in the First Half of the Twenty-First Century.二十一世纪上半叶疫苗学家面临的挑战。
Methods Mol Biol. 2022;2410:3-25. doi: 10.1007/978-1-0716-1884-4_1.
8
Genome-based vaccine design: the promise for malaria and other infectious diseases.基于基因组的疫苗设计:对疟疾和其他传染病的前景
Int J Parasitol. 2014 Oct 15;44(12):901-13. doi: 10.1016/j.ijpara.2014.07.010. Epub 2014 Sep 6.
9
Malaria vaccine.疟疾疫苗
Indian J Pathol Microbiol. 1996 Dec;39(5):433-41.
10
New approaches in vaccine development.疫苗研发的新方法。
Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):329-41. doi: 10.1016/S0147-9571(03)00018-3.

引用本文的文献

1
VO: The Vaccine Ontology.VO:疫苗本体论。
bioRxiv. 2025 Aug 15:2025.08.12.669998. doi: 10.1101/2025.08.12.669998.
2
Advances in Nanotechnology Research in Food Production, Nutrition, and Health.纳米技术在食品生产、营养与健康领域的研究进展。
Nutrients. 2025 Jul 26;17(15):2443. doi: 10.3390/nu17152443.
3
mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases.用于对抗人畜共患病毒性疾病的mRNA疫苗研发

本文引用的文献

1
Structure and function of respiratory syncytial virus surface glycoproteins.呼吸道合胞病毒表面糖蛋白的结构与功能。
Curr Top Microbiol Immunol. 2013;372:83-104. doi: 10.1007/978-3-642-38919-1_4.
2
Breakthrough of the year 2013. Cancer immunotherapy.2013年度重大突破。癌症免疫疗法。
Science. 2013 Dec 20;342(6165):1432-3. doi: 10.1126/science.342.6165.1432.
3
GSK plows ahead with EMA malaria vaccine submission.葛兰素史克推进向欧洲药品管理局提交疟疾疫苗申请。
Viruses. 2025 Jul 8;17(7):960. doi: 10.3390/v17070960.
4
Trained Innate Immunity.训练有素的固有免疫
Adv Exp Med Biol. 2025;1476:275-296. doi: 10.1007/978-3-031-85340-1_11.
5
Evaluation of the Immunostimulatory Effect of Ulvan Polysaccharide on Human Macrophages: Use as a Potential Vaccine Adjuvant.岩藻多糖对人巨噬细胞免疫刺激作用的评估:作为潜在疫苗佐剂的应用。
Mar Drugs. 2025 Jun 11;23(6):248. doi: 10.3390/md23060248.
6
Covalent Functionalization of Layered Double Hydroxides to Generate Peptide-Based SARS-CoV-2 Nanovaccine.层状双氢氧化物的共价功能化以生成基于肽的SARS-CoV-2纳米疫苗
Materials (Basel). 2025 May 23;18(11):2449. doi: 10.3390/ma18112449.
7
Molecular mechanisms of immune evasion by host protein glycosylation of a bacterial immunogen used in nucleic acid vaccines.核酸疫苗中使用的细菌免疫原通过宿主蛋白糖基化实现免疫逃逸的分子机制。
bioRxiv. 2025 May 30:2025.05.29.656815. doi: 10.1101/2025.05.29.656815.
8
Feed containing heat-killed lactic acid bacteria as a single species or multispecies combination improves feeding, defense, and stress in coho salmon.含有单一或多种组合的热灭活乳酸菌的饲料可改善银大麻哈鱼的摄食、防御能力及应激反应。
Physiol Rep. 2025 Apr;13(7):e70324. doi: 10.14814/phy2.70324.
9
'It was just the given thing to do': exploring enablers for high childhood vaccination uptake in East London's Bangladeshi community-a qualitative study.“这是自然而然要做的事”:探索东伦敦孟加拉社区儿童高疫苗接种率的促成因素——一项定性研究
BMJ Public Health. 2025 Jan 16;3(1):e001004. doi: 10.1136/bmjph-2024-001004. eCollection 2025 Jan.
10
A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture.一种包含具有N端抗原捕获功能的乙肝病毒核心蛋白的病毒样颗粒疫苗平台。
Int J Biol Macromol. 2025 May;305(Pt 2):141152. doi: 10.1016/j.ijbiomac.2025.141152. Epub 2025 Feb 15.
Nat Biotechnol. 2013 Dec;31(12):1066. doi: 10.1038/nbt1213-1066a.
4
Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.合成DNA疫苗:通过电穿孔和共递送基因佐剂提高疫苗效力。
Front Immunol. 2013 Nov 4;4:354. doi: 10.3389/fimmu.2013.00354.
5
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.基于结构的融合糖蛋白疫苗设计用于呼吸道合胞病毒。
Science. 2013 Nov 1;342(6158):592-8. doi: 10.1126/science.1243283.
6
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.Cryo-EM 结构的完全糖基化可溶性裂解 HIV-1 包膜三聚体。
Science. 2013 Dec 20;342(6165):1484-90. doi: 10.1126/science.1245627. Epub 2013 Oct 31.
7
Crystal structure of a soluble cleaved HIV-1 envelope trimer.可溶性 HIV-1 包膜三聚体的晶体结构
Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31.
8
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.高效中和 HIV-1 特异性单克隆抗体在感染猴免疫缺陷病毒的恒河猴中的治疗效果。
Nature. 2013 Nov 14;503(7475):224-8. doi: 10.1038/nature12744. Epub 2013 Oct 30.
9
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.抗体制剂免疫疗法抑制慢性感染猴 HIV 的病毒血症
Nature. 2013 Nov 14;503(7475):277-80. doi: 10.1038/nature12746. Epub 2013 Oct 30.
10
Live-attenuated bacteria as a cancer vaccine vector.活减细菌作为癌症疫苗载体。
Expert Rev Vaccines. 2013 Oct;12(10):1139-54. doi: 10.1586/14760584.2013.836914.